Press release
Induced Pluripotent Stem Cells Market to Grow at 7.3% CAGR by 2032, Says Persistence Market Research
Induced Pluripotent Stem Cells Market
The global induced pluripotent stem cells (iPSCs) market is on a growth trajectory, fueled by increasing demand in regenerative medicine, disease modeling, and drug discovery. According to Persistence Market Research, the iPSCs market is expected to be valued at US$ 2,051.9 Mn in 2025 and reach US$ 3,360.0 Mn by 2032, expanding at a CAGR of 7.3% during the forecast period. These cells, reprogrammed from adult somatic cells to mimic embryonic stem cells, offer self-renewal and pluripotency, making them ideal for personalized therapeutics and high-throughput drug screening.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/17968
A key growth driver is the rising global burden of chronic and degenerative diseases such as Parkinson's, Alzheimer's, cardiovascular diseases, and diabetes. These conditions are increasing the demand for iPSC-based disease models and regenerative approaches. In 2024, iPSC-derived hepatocytes accounted for the largest market share due to their utility in liver disease modeling and drug metabolism studies. Geographically, North America is leading the market with a dominant 39.2% share, supported by significant R&D funding, a strong biotechnology infrastructure, and an increasing rate of iPSC adoption in advanced therapeutics.
✦ Key Highlights from the Report
✦ The iPSCs market is forecasted to grow at a CAGR of 7.3% between 2025 and 2032.
✦ Rising incidences of neurodegenerative disorders and diabetes are major growth catalysts.
✦ iPSC-derived hepatocytes held 33.0% market share in 2024 due to extensive applications in liver research.
✦ Surge in public and private funding is fostering R&D, especially in the U.S., Japan, and Europe.
✦ iPSC-derived fibroblasts are projected to register the highest CAGR through 2032.
✦ Pharmaceutical and biotech companies are leading end users, with a 59.6% market share in 2024.
📊 Market Segmentation
The induced pluripotent stem cells market can be segmented based on cell type and application. By cell type, neurons dominate the market, driven by rising prevalence of neurological disorders and the suitability of neurons for neurodegenerative disease modeling. These cells enable the development of patient-specific therapies and aid in studying complex neural mechanisms.
In terms of application, pharmaceutical and biotechnology companies are the leading end-users, accounting for nearly 59.6% of the market share in 2024. These companies are heavily investing in the development of iPSC-based regenerative therapies and drug discovery pipelines. Academic and research institutes, while smaller in market share, are projected to grow rapidly owing to increasing adoption of iPSC technology in therapeutic research and disease modeling.
🌍 Regional Insights
North America continues to dominate the global iPSCs market due to its advanced healthcare infrastructure, rising chronic disease burden, and strong government funding. The U.S. alone has allocated over US$2 billion for stem cell research in recent years. Initiatives in micromedicine and personalized medicine are further encouraging iPSC adoption for drug screening and efficacy testing.
Europe is witnessing robust growth, with the UK, Germany, and France making significant contributions. Strong regulatory frameworks, investment in clinical trials, and active collaboration between academia and industry are driving the European iPSC market. The UK's focus on regenerative medicine and Germany's advancements in biopharmaceuticals are particularly notable.
Asia-Pacific is emerging as a high-growth region, propelled by government initiatives in Japan, China, and India to support stem cell research. Japan's establishment of iPSC banks and China's biotechnology expansion signal a favorable market environment. The region also benefits from a large aging population, increasing the demand for regenerative therapies.
🚀 Market Drivers
A major driver for the iPSC market is the global rise in chronic and degenerative diseases. According to WHO (2024), non-communicable diseases account for 74% of all global deaths. Conditions like Alzheimer's and Parkinson's are increasing, necessitating more effective disease models and treatment strategies. iPSC-derived models help in understanding disease progression and personalizing therapeutic approaches. Additionally, advancements in gene editing, 3D bioprinting, and high-throughput screening are enabling new applications for iPSCs.
⛔ Market Restraints
Despite promising potential, the market is constrained by the high cost of iPSC derivation and cell line development. Many labs, especially those with limited funding, hesitate to invest in expensive custom cell products. Operational complexities and the uncertain outcome of research further limit widespread adoption. Moreover, the premium pricing of high-quality reagents and tools deters smaller players from entering or expanding within the market.
✨ Market Opportunities
The growing use of iPSCs in regenerative medicine and the rising demand for personalized therapies represent significant opportunities. With projections indicating that Alzheimer's could affect 13 million Americans by 2060, iPSC-derived models offer potential breakthroughs in understanding and treating such diseases. Innovations such as CRISPR gene editing and automated cell culture systems are making iPSC applications more scalable and cost-effective. Strategic alliances between biotech firms and academic centers are also paving the way for new therapeutic avenues and commercial success.
Do You Have Any Query Or Specific Requirement? Request Customization of Report: https://www.persistencemarketresearch.com/request-customization/17968
Frequently Asked Questions (FAQs)
How Big is the Global Induced Pluripotent Stem Cells Market?
Who are the Key Players in the Global Market for iPSCs?
What is the Projected Growth Rate of the Induced Pluripotent Stem Cells Market?
What is the Market Forecast for iPSCs by 2032?
Which Region is Estimated to Dominate the iPSCs Industry through the Forecast Period?
📈 Company Insights
• Thermo Fisher Scientific
• FUJIFILM Cellular Dynamics
• REPROCELL Inc.
• Takara Bio Inc.
• ViaCyte, Inc.
• Fate Therapeutics
• Ncardia
• Axol Bioscience Ltd.
• Sumitomo Dainippon Pharma Co., Ltd.
• Cynata Therapeutics
Recent Industry Developments
In April 2024, Shinobi partnered with Panasonic and Kyoto University to develop an iPSC platform for T-cell therapies.
In February 2024, a British pharmaceutical company invested $300 million in a new facility in Rockville, Maryland to advance cell therapy platforms.
In January 2024, the Abu Dhabi Stem Cells Center partnered with Kyoto University's CiRA and Rege Nephro to conduct joint research in iPSC-based renal therapies.
Conclusion
The global induced pluripotent stem cells market is on a promising path of growth, underpinned by scientific advances, increasing healthcare needs, and a paradigm shift toward personalized medicine. While high costs and technical challenges persist, opportunities abound for companies that innovate in regenerative medicine, disease modeling, and therapeutic development. With strong support from both public and private sectors, and the proliferation of cutting-edge technologies, the iPSC industry is poised to revolutionize the future of biomedical science. As demand intensifies across regions, stakeholders are urged to invest in scalable, efficient, and patient-centric solutions to harness the full potential of iPSC technology.
Like & Follow Us:
https://www.linkedin.com/newsletters/medtech-hub-7281980855462297600/
https://www.linkedin.com/newsletters/smarttech-industries-7281982219085099008/
https://www.linkedin.com/newsletters/the-semicon-update-7282654083763621888/
https://www.youtube.com/@InsightfulAnalytics-q7v/videos
https://www.facebook.com/profile.php
https://www.instagram.com/persistenceinsights/
https://x.com/pmrinsights
Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com
About Persistence Market Research:
At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.
Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Induced Pluripotent Stem Cells Market to Grow at 7.3% CAGR by 2032, Says Persistence Market Research here
News-ID: 4080665 • Views: …
More Releases from Persistence Market Research
Safety Light Curtain Market Expansion Fueled by Automation - Persistence Market …
The Safety Light Curtain market has gained significant traction over the past few years, owing to the increasing emphasis on worker safety in manufacturing facilities. Manufacturing units across various industries rely on machines that operate at high speeds, such as presses, cutters, and welders, which present significant risks to operators. As businesses strive for greater efficiency in assembly lines, the need for robust safety measures becomes more critical. Safety light…
Air-Operated Double Diaphragm (AODD) Pump Market to Surpass US$ 3.1 Bn by 2032, …
Market Overview and Outlook
The global Air-Operated Double Diaphragm (AODD) pump market is projected to grow significantly, from a valuation of US$ 2,153.8 million in 2025 to US$ 3,111.1 million by 2032, exhibiting a steady CAGR of 5.4% over the forecast period. The market's expansion is underpinned by the surging need for hygienic, efficient, and automated fluid transfer systems in industries such as pharmaceuticals, food and beverage, and water treatment.
Get a…
Digital Platforms Market Poised to Transform Business Models, Says Persistence M …
The digital platforms market has become one of the most rapidly growing industries globally, largely driven by the increasing demand for businesses to enhance their digital presence. These platforms help organizations deliver superior customer experiences, facilitate digital asset management, and improve overall operational efficiency. The evolution of advanced technologies like cloud computing, Internet of Things (IoT), artificial intelligence (AI), and analytics are key enablers of this growth, as they empower…
Wireless Keyboards Market Growth Accelerates with Demand for Smart Devices - Per …
The wireless keyboard market is witnessing significant growth, driven by a blend of technological advances, evolving user preferences, and an increasing need for mobility in personal and professional environments. As of 2022, the market was valued at approximately US$ 1,389.8 million, and projections suggest it will nearly double to US$ 2,773.7 million by 2033. The market is expected to grow at a compound annual growth rate (CAGR) of 6.6% from…
More Releases for Stem
Stem Cells Market: Development of Infrastructure to Drive Global Stem Cells Mark …
In the global stem cells market a sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share. Further, they are also forging partnerships with pharmaceutical organizations to up revenues.
Read Report Overview - https://www.transparencymarketresearch.com/stem-cells-market.html
In addition, companies in the global stem cells market are pouring money into expansion through multidisciplinary and multi-sector collaboration for large…
Global Animal Stem Cell Therapy Market Detailed Analysis 2018-2025 : MediVet Bio …
Qyresearchreports include new market research report “Global Animal Stem Cell Therapy Market Research Report 2018” to its huge collection of research reports.
Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process…
Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives
MarketResearchReports.Biz adds “Global Stem Cell Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Stem Cell and the growth estimates for the forecasted period.
Stem cell research has been in process for over five decades. Stem cells have a unique ability to divide and replicate repeatedly, as well as an “unspecialized” nature that allows them to differentiate into a…
Autologous Stem Cell and Non-Stem Cell Based Therapies Market
Autologous stem-cell transplantation (also known as autogeneic, autogenic, or autogenous stem-cell transplantation or auto-SCT) is the autologous transplantation of stem cells—which is, transplantation in which the undifferentiated cells or stem cells (cells from which other types of cells develop) are taken from a person, accumulated, and given back to the same person later. Even though it is most often executed by means of hematopoietic stem cells (antecedent of cells that…
Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell …
Researchmoz added Most up-to-date research on "Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell, Embryonic Stem Cell & Adult Stem Cell" to its huge collection of research reports.
In this report, the global Stem Cell Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between…
Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem …
Researchmoz added Most up-to-date research on "Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem Cell Culture, Neural Stem Cell Culture & Mesenchymal Stem Cell Culture" to its huge collection of research reports.
In this report, the global Stem Cell Media market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a…
